# Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery

> **NCT04754230** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 40 (actual)

## Conditions studied

- Chronic Sinusitis
- Nasal Obstruction
- Turbinate; Hypertrophy Mucous Membrane
- Deviated Nasal Septum - Congenital
- Deviated Nasal Septum Acquired

## Interventions

- **DRUG:** Tranexamic Acid 1,000 Mg/10 mL (100 Mg/mL) INTRAVEN VIAL (ML)

## Key facts

- **NCT ID:** NCT04754230
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-17
- **Primary completion:** 2022-02-20
- **Final completion:** 2022-02-20
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04754230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04754230, "Effect of Tranexamic Acid on Postoperative Bleeding Following Sinus and Nasal Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04754230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*